News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|December 29, 2022

Importance of Screening for T1D

Author(s)Tina Q Tan, MD, FAAP, FIDSA, FPIDS, Kimberly Simmons, MD

Tina Q Tan, MD, and Kimberly Simmons, MD, comment on early screening for pediatric T1D, screening options, and next steps once a child has tested positive for 2 or more autoantibodies.

Episodes in this series

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 2 Stages and Progression of T1D

EP. 2 Stages and Progression of T1D

EP. 3 Importance of Screening for T1D

EP. 3 Importance of Screening for T1D

EP. 4 Lifestyle Management in T1D

EP. 4 Lifestyle Management in T1D

EP. 5 Approaching T1D Screening Retesting

EP. 5 Approaching T1D Screening Retesting

EP. 6 Emerging Treatments in T1D

EP. 6 Emerging Treatments in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care | Image Credit: © H_Ko - stock.adobe.com.

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care

ByHerb Bravo, MD,Dan Feiten, MD,Andrew Cagle, MD

November 20th 2025

Artificial sweeteners show mixed effects on diabetes management | Image Credit: © Proxima Studio - stock.adobe.com.

Artificial sweeteners show mixed effects on diabetes management

ByMorgan Ebert, Managing Editor

November 2nd 2025

Novel therapies for type 1 diabetes | Image Credit: © martenaba - stock.adobe.com.

Novel therapies for type 1 diabetes

ByMichelle Nieland, PharmD ,Carlton Lee, PharmD, MPH, FASHP, FPPAG, BCPPS

November 1st 2025

FDA accepts Afrezza sBLA for pediatric diabetes | Image credit: Contemporary Pediatrics

FDA accepts Afrezza sBLA for pediatric diabetes

ByMorgan Ebert, Managing Editor,Joshua Fitch, Senior Editor

October 13th 2025

What to expect from the 2025 AAP National Conference & Exhibition | Image Credit: © KOTO - stock.adobe.com.

What to expect from the 2025 American Academy of Pediatrics National Conference & Exhibition

ByJoshua Fitch, Senior Editor

September 23rd 2025

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

ACIP votes to update hepatitis B vaccine recommendation for infants

New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants

Hepatitis B Foundation president discusses recommendations for infant vaccination

Repeal of nonmedical exemptions linked to rise in kindergarten vaccination rates

FDA expands indication for MED-EL cochlear implants to infants 7 months or older

© 2025 MJH Life Sciences^®

All rights reserved.